Clinical trial NCT05907551: Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
Official title: Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Neoplasms
Lead sponsor: Institut de cancérologie Strasbourg Europe
Sponsor class: OTHER
First posted: 2023-06-18
Enrollment: 210
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: This study will enroll patients with solid tumors in 7 different cohorts according to tumor location (30 patients per location)

Brief summary: Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment.

The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.

Detailed description: This study aims at establishing, in a cohort of patients with solid tumors, the state of their knowledges, given information and their financial capacities regarding access to dermo-cosmetics and aesthetic solutions, that are used in the attenuation of cancer treatments' side-effects.

Eligibility criteria: Inclusion Criteria:

* Age \> 18 years
* Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers)
* Patients able to read and understand French
* Patients that has expressed their consent and with signed consent form

Exclusion Criteria:

* Minor or patients placed under guardianship or supervision
* Patients unable to read French
* Patients placed under judicial protection

Primary outcomes:
measure: Describe patients' knowledges regarding cutaneous side-effects, nail and hair toxicities induced by anticancer drugs
timeFrame: at inclusion
measure: Describe patients' knowledges regarding dermo-cosmetics and aesthetic solutions that can attenuate cutaneous side-effects, nail and hair toxicities induced by anticancer drugs
timeFrame: at inclusion
Secondary outcomes:
measure: Describe patients' socio-economic profile to assess equity regarding access to dermo-cosmetics and aesthetic solutions
timeFrame: at inclusion
measure: Correlate patients' knowledge level depending on tumoral location
timeFrame: at inclusion
measure: Correlate patients' knowledge level depending on received treatment
timeFrame: at inclusion
measure: Correlate patients' knowledge level depending on treatment phase
timeFrame: at inclusion
Other outcomes:
Locations:
city: Strasbourg
country: France
facility: Institut de cancérologie Strasbourg Europe
Study officials:
affiliation: Institut de cancérologie Strasbourg Europe
name: Nelly ETIENNE-SELLOUM, PharmD
role: STUDY_CHAIR
References: